Ligustilide can upregulate the expression of p-pI3k, p-Akt, and p-mTOR proteins in the brain of rats with cerebral ischemia–reperfusion and show the activation of the PI3K/Akt/mTOR pathway. Here, AKT1 is linked to brain ischemia.